Literature DB >> 33772143

Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant.

Courtney D DiNardo1, Eytan M Stein2, Arnaud Pigneux3, Jessica K Altman4, Robert Collins5, Harry P Erba6, Justin M Watts7, Geoffrey L Uy8, Thomas Winkler9, Hongfang Wang9, Sung Choe9, Hua Liu9, Bin Wu9, Stephanie M Kapsalis9, Gail J Roboz10, Stéphane de Botton11.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33772143      PMCID: PMC8464620          DOI: 10.1038/s41375-021-01229-x

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  1 in total

Review 1.  Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.

Authors:  Mohammad Faizan Zahid; Umair Arshad Malik; Momena Sohail; Irfan Nazir Hassan; Sara Ali; Muhammad Hamza Saad Shaukat
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.